Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebekah G Langston

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Neurology|September 28, 2018
Use of a Modified STROOP Test to Assess Color Discrimination Deficit in Parkinson's DiseaseRebekah G Langston, Tuhin Virmani
Progress in Brain Research|April 6, 2020
Pathways of protein synthesis and degradation in PD pathogenesisRebekah G Langston, Mark R Cookson
The Biochemical Journal|January 27, 2016
The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical researchRebekah G Langston, Iakov N Rudenko, Mark R Cookson
Journal of Neurosurgery|February 10, 2019
Characteristics and career outcomes of Neurosurgery Research and Education Foundation research fellowship recipientsTaylor A Wilson, Rebekah G Langston, Ka Hin Wong, et al.
Organic & Biomolecular Chemistry|March 27, 2014
Evaluating N-benzylgalactonoamidines as putative transition state analogs for β-galactoside hydrolysisQiu-Hua Fan, Susanne Striegler, Rebekah G Langston, et al.
Stem Cell Research|June 5, 2021
Generation of fourteen isogenic cell lines for Parkinson's disease-associated leucine-rich repeat kinase (LRRK2)Aleksandra Beylina, Rebekah G Langston, Dorien Rosen, et al.
Eneuro|October 15, 2015
The Polg Mutator Phenotype Does Not Cause Dopaminergic Neurodegeneration in DJ-1-Deficient MiceDavid N Hauser, Christopher T Primiani, Rebekah G Langston, et al.
Science Translational Medicine|July 27, 2022
Association of a common genetic variant with Parkinson's disease is mediated by microgliaRebekah G Langston, Alexandra Beilina, Xylena Reed, et al.
Clinical Neurology and Neurosurgery|August 13, 2023
Intracranial hematolymphoid malignancies: A case series with molecular characterizationRebekah G Langston, Heather Pinckard-Dover, Grace Guzman, et al.
The Biochemical Journal|March 22, 2017
The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2Iakov N Rudenko, Alice Kaganovich, Rebekah G Langston, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Neurology|September 28, 2018
Use of a Modified STROOP Test to Assess Color Discrimination Deficit in Parkinson's DiseaseRebekah G Langston, Tuhin Virmani
Progress in Brain Research|April 6, 2020
Pathways of protein synthesis and degradation in PD pathogenesisRebekah G Langston, Mark R Cookson
The Biochemical Journal|January 27, 2016
The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical researchRebekah G Langston, Iakov N Rudenko, Mark R Cookson
Journal of Neurosurgery|February 10, 2019
Characteristics and career outcomes of Neurosurgery Research and Education Foundation research fellowship recipientsTaylor A Wilson, Rebekah G Langston, Ka Hin Wong, et al.
Organic & Biomolecular Chemistry|March 27, 2014
Evaluating N-benzylgalactonoamidines as putative transition state analogs for β-galactoside hydrolysisQiu-Hua Fan, Susanne Striegler, Rebekah G Langston, et al.
Stem Cell Research|June 5, 2021
Generation of fourteen isogenic cell lines for Parkinson's disease-associated leucine-rich repeat kinase (LRRK2)Aleksandra Beylina, Rebekah G Langston, Dorien Rosen, et al.
Eneuro|October 15, 2015
The Polg Mutator Phenotype Does Not Cause Dopaminergic Neurodegeneration in DJ-1-Deficient MiceDavid N Hauser, Christopher T Primiani, Rebekah G Langston, et al.
Science Translational Medicine|July 27, 2022
Association of a common genetic variant with Parkinson's disease is mediated by microgliaRebekah G Langston, Alexandra Beilina, Xylena Reed, et al.
Clinical Neurology and Neurosurgery|August 13, 2023
Intracranial hematolymphoid malignancies: A case series with molecular characterizationRebekah G Langston, Heather Pinckard-Dover, Grace Guzman, et al.
The Biochemical Journal|March 22, 2017
The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2Iakov N Rudenko, Alice Kaganovich, Rebekah G Langston, et al.
Pageof 3